PRE
Prenetics Global LtdKey Statistics
About Prenetics Global Ltd
Prenetics Global Ltd (PRE) is a leading health technology innovator specializing in genetic and diagnostic testing, leveraging advanced technologies to provide essential health insights for consumers and healthcare professionals alike. The company boasts a comprehensive portfolio of cutting-edge genetic testing solutions and integrated digital health services, driving its robust international growth through strategic partnerships and an unwavering dedication to research and development. Positioned at the forefront of personalized medicine, Prenetics is well-equipped to meet the growing consumer demand for accessible and actionable health information, making it a compelling investment opportunity in the rapidly evolving healthcare sector.
Fundamentals
| Revenue (TTM) | $92.39M |
| Gross Profit (TTM) | $48.94M |
| EBITDA | $-32.97M |
| Operating Margin | -33.30% |
| Return on Equity | -31.80% |
| Return on Assets | -11.00% |
| Revenue/Share (TTM) | $6.57 |
| Book Value | $10.89 |
| Price-to-Book | 1.78 |
| Price-to-Sales (TTM) | 3.32 |
| EV/Revenue | 2.718 |
| EV/EBITDA | 0.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 248.60% |
| Shares Outstanding | $15.29M |
| Float | $12.01M |
| % Insiders | 18.18% |
| % Institutions | 13.95% |
Historical Volatility
Volatility is currently contracting